Follow
izzettin guler
izzettin guler
Verified email at gantep.edu.tr
Title
Cited by
Cited by
Year
Antitumoral effect of a selective Rho-kinase inhibitor Y-27632 against Ehrlich ascites carcinoma in mice
D Isler, M Ozaslan, ID Karagoz, IH Kilic, M Karakok, S Taysi, I Guler, ...
Pharmacological Reports 66 (1), 114-120, 2014
192014
Hepatoprotective effect of diffractaic acid on carbon tetrachloride-induced liver damage in rats
ID Karagoz, M Ozaslan, IH Kilic, I Guler, C Uyar, D Tuter, U Kazanci, ...
Biotechnology & Biotechnological Equipment 29 (5), 1011-1016, 2015
172015
In vivo antitumoral effect of diffractaic acid from lichen metabolites on Swiss albino mice with Ehrlich Ascites Carcinoma: an experimental study.
ID Karagoz, M Ozaslan, I Guler, C Uyar, T Yalim, U Kazanci, A Aslan, ...
International Journal of Pharmacology 10 (6), 307-314, 2014
142014
Cytotoxic and anti-proliferative activities of the Tetrapleura tetraptera fruit extract on Ehrlich ascites tumor cells
M Ozaslan, ID Karagoz, RA Lawal, IH Kilic, A Cakir, OS Odesanmi, I Guler, ...
ASIAN NETWORK SCIENTIFIC INFORMATION-ANSINET, 2016
132016
Mutation analysis of protein kinase binding domain of HCV NS5A gene isolated from patients with chronic hepatitis C.
IH Kilic, MM Koruk, M Ozaslan, ID Karagoz, Y Zer, M Koruk, C Uyar, ...
32012
Cytotoxic activity of croton penduliflorus (Euphorbiaceae) seed oil against ehrlich ascites carcinoma cells.
AS Ojokuku, OS Odesanmi, AR Lawal, AO Magbagbeola, MD Ozaslan, ...
12018
Investigation of Antitumor Activity of Phycocyanin Obtained from Spirulina (Arthrospira) platensis in Mice
SB Oguzkan, I Guler, BK Guroy, K Bakir, M Ozaslan
INTERNATIONAL JOURNAL OF PHARMACOLOGY 19 (1), 114-121, 2023
2023
The system can't perform the operation now. Try again later.
Articles 1–7